Allurion Technologies (ALURD) Cash & Current Investments (2022 - 2026)

Allurion Technologies (ALURD) Cash & Current Investments (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 7.30 Bn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 2.88 Bn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 3.67 Bn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 2.29 Bn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 1.12 Bn
8 Smith & Nephew 28.19 Bn 27.62 Bn - 577.00 Mn
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 3.04 Bn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn 5.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.06 Mn
Dec 31, 2025 5.41 Mn
Sep 30, 2025 6.14 Mn
Jun 30, 2025 12.72 Mn
Mar 31, 2025 20.41 Mn
Dec 31, 2024 15.38 Mn
Sep 30, 2024 28.65 Mn
Jun 30, 2024 19.26 Mn
Mar 31, 2024 29.68 Mn
Dec 31, 2023 38.04 Mn
Sep 30, 2023 79.87 Mn
Jun 30, 2023 4.74 Mn
Dec 31, 2022 7.69 Mn